Literature DB >> 11733538

Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice.

Marcus Harbord1, Marco Novelli, Benito Canas, David Power, Christine Davis, Jasminka Godovac-Zimmermann, Jurgen Roes, Anthony W Segal.   

Abstract

Crystals were discovered within the aged lung and at sites of chronic inflammation in a mouse model of chronic granulomatous disease. Following re-crystallization at neutral pH, the crystals were identified as the chitinase-like protein Ym1, expressed in organs of the lymphoreticular system, the lung, and distal stomach. Ym1 was shown to be a neutrophil granule protein and to have weak beta-N-acetylglucosaminidase activity, indicating that it might contribute to the digestion of glycosaminoglycans. Crystal formation is likely to be a function of excess neutrophil turnover at sites of inflammation in the chronic granulomatous disease mouse. Failure to remove subcutaneous Ym1 crystals injected into knockout mice indicates that a failure of digestion may also contribute to crystallization.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733538     DOI: 10.1074/jbc.M110635200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy.

Authors:  Meera G Nair; Katherine J Guild; David Artis
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

2.  Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells.

Authors:  Meera G Nair; Iain J Gallagher; Matthew D Taylor; P'ng Loke; Patricia S Coulson; R A Wilson; Rick M Maizels; Judith E Allen
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 4.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  Proceedings of the 2012 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Brian R Berridge; Michael C Boyle; Michelle C Cora; Mark J Hoenerhoff; Linda Kooistra; Victoria A Laast; James P Morrison; Deepa Rao; Matthias Rinke; Katsuhiko Yoshizawa
Journal:  Toxicol Pathol       Date:  2012-12-21       Impact factor: 1.902

6.  Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4.

Authors:  Jian-Mei Li; Lampson M Fan; Michael R Christie; Ajay M Shah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  The phenotype of murine wound macrophages.

Authors:  Jean M Daley; Samielle K Brancato; Alan A Thomay; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2010-01       Impact factor: 4.962

8.  Human chitinases and chitinase-like proteins as indicators for inflammation and cancer.

Authors:  Julia Kzhyshkowska; Alexei Gratchev; Sergij Goerdt
Journal:  Biomark Insights       Date:  2007-05-03

9.  Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements.

Authors:  Anne M Sanders; John R Stehle; Michael J Blanks; Gregory Riedlinger; Jung W Kim-Shapiro; Arta M Monjazeb; Jonathan M Adams; Mark C Willingham; Zheng Cui
Journal:  BMC Cancer       Date:  2010-03-31       Impact factor: 4.430

10.  IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness.

Authors:  Benjamin G Dewals; Reece G Marillier; Jennifer C Hoving; Mosiuoa Leeto; Anita Schwegmann; Frank Brombacher
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.